Cargando…

Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) most often develops in patients with underlying liver disease characterized by chronic nonresolving inflammation. Tumor-associated macrophages (TAMs) are one of the most abundant immune cell populations within the tumoral microenvironment. As key actors of cancer-relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Degroote, H., Van Dierendonck, A., Geerts, A., Van Vlierberghe, H., Devisscher, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206557/ https://www.ncbi.nlm.nih.gov/pubmed/30410942 http://dx.doi.org/10.1155/2018/7819520

Ejemplares similares

Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models
por: Degroote, Helena, et al.
Publicado: (2021)

NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma
por: Vandierendonck, Astrid, et al.
Publicado: (2021)

Effect of isoform-specific HIF-1α and HIF-2α antisense oligonucleotides on tumorigenesis, inflammation and fibrosis in a hepatocellular carcinoma mouse model
por: Vanderborght, Bart, et al.
Publicado: (2020)

Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation
por: Degroote, Helena, et al.
Publicado: (2022)

The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
por: Vanderborght, Bart, et al.
Publicado: (2020)

Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium
por: Verhelst, Xavier, et al.
Publicado: (2021)

The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
por: De Muynck, Kevin, et al.
Publicado: (2021)

The neurogliovascular unit in hepatic encephalopathy
por: Claeys, Wouter, et al.
Publicado: (2021)

Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2016)

Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2016)

Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis
por: Bogaerts, Eliene, et al.
Publicado: (2016)

Cerebellar stroke in a low cardiovascular risk patient associated with sorafenib treatment for fibrolamellar hepatocellular carcinoma
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2014)

Time-Dependent Effect of Hypoxia on Tumor Progression and Liver Progenitor Cell Markers in Primary Liver Tumors
por: Bogaerts, Eliene, et al.
Publicado: (2015)

Rare case of ascites several years after liver transplantation
por: Deroo, Liesbeth, et al.
Publicado: (2022)

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma
por: Yuan, Yi, et al.
Publicado: (2023)

Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis
por: Paridaens, Annelies, et al.
Publicado: (2017)

Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma
por: Liu, Qiaoyun, et al.
Publicado: (2023)

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
por: Zheng, Hongyu, et al.
Publicado: (2023)

Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma
por: Heindryckx, Femke, et al.
Publicado: (2010)

Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy
por: Vandewynckel, Yves-Paul, et al.
Publicado: (2014)

Focal eosinophilic infiltration of the liver, benign or malignant?
por: Claeys, Wouter, et al.
Publicado: (2021)

Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages
por: Zhou, Jingyi, et al.
Publicado: (2021)

The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
por: Huang, Yu, et al.
Publicado: (2021)

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling
por: Romualdo, Guilherme Ribeiro, et al.
Publicado: (2021)

Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study
por: Ma, Di, et al.
Publicado: (2020)

Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
por: Zhou, Dexi, et al.
Publicado: (2021)

Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
por: Lee, Hsin-Lun, et al.
Publicado: (2023)

Macrophages and hepatocellular carcinoma
por: Tian, Zhiqiang, et al.
Publicado: (2019)

Lighter serum copper isotopic composition in patients with early non-alcoholic fatty liver disease
por: Van Campenhout, Sanne, et al.
Publicado: (2020)

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2022)

Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma
por: Merle, Philippe
Publicado: (2023)

Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
por: Zhu, Shuangli, et al.
Publicado: (2021)

Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications
por: Zhang, Qian, et al.
Publicado: (2020)

TRLS-04. PRECLINICAL VALIDATION OF A NOVEL THERAPEUTIC STRATEGY FOR CHOROID PLEXUS CARCINOMA
por: Martin, Brice, et al.
Publicado: (2023)

Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
por: Arvanitakis, Konstantinos, et al.
Publicado: (2022)

Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma
por: Wang, Weining, et al.
Publicado: (2015)

Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective
por: Blidisel, Alexandru, et al.
Publicado: (2021)

Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma
por: Yao, Min, et al.
Publicado: (2014)

Multi-target siRNA: Therapeutic Strategy for Hepatocellular Carcinoma
por: Li, Tiejun, et al.
Publicado: (2016)

Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
por: Yao, Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nugfq53cv26e0pbd7ksn7shcse